Dr. Manju Schorr, MD (she/her) is an Endocrinologist in Yuma, AZ with over 16 years of experience. What is your opinion of Dr. Manju Schorr, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Manju Schorr, MD has received over $480,185 which includes payments from the following companies:
$232,426.40 from AstraZeneca Pharmaceuticals LP
$93,118.76 from Janssen Pharmaceuticals, Inc
$81,051.70 from AbbVie, Inc.
$63,507.71 from sanofi-aventis U.S. LLC
$2,146.84 from Novo Nordisk Inc
$1,372.04 from Medtronic MiniMed, Inc.
$948.20 from Merck Sharp & Dohme Corporation
$836.53 from Shire North American Group Inc
$717.01 from Tandem Diabetes Care, Inc.
$479.71 from Roche Diagnostics Corporation
$368.53 from Amgen Inc.
$339.75 from Dexcom, Inc.
$320.90 from GlaxoSmithKline, LLC.
$311.30 from Corcept Therapeutics
$292.98 from MannKind Corporation
$250.00 from E.R. Squibb & Sons, L.L.C.
$243.76 from Roche Diabetes Care, Inc.
$199.79 from LILLY USA, LLC
$161.39 from Janssen Scientific Affairs, LLC
$152.02 from Boehringer Ingelheim Pharmaceuticals, Inc.
Payments received by Dr. Manju Schorr, MD were from the following categories:
$423,741.50 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!